BRING-UP Prevention
NCT06275113
Summary
The aim of this observational study is to assess in patients with a documented athero-thrombotic event: coronary artery disease (CAD), cerebrovascular disease (CVD), peripheral artery disease (PAD): * the level of adherence to guideline recommendations with the assumption to improve the rate of patients at goal for cholesterol levels. * the level of adherence to guideline recommendations and the rate of patients at goal for the other relevant and modifiable risk factors for cardiovascular event recurrence.
Eligibility
Inclusion Criteria: * Both sexes at birth, age ≥18 years At least one of the following clinical conditions: * Documented CAD defined as: * Prior Acute Coronary Syndrom (ACS) * Prior Coronary Artery Bypass Graft (CABG) * Prior Percutaneous Coronary Intervention (PCI) * Documented PAD (previous peripheral bypass surgery or angioplasty, limb or foot amputation, intermittent claudication with objective evidence of peripheral artery disease, Ankle Brachial Index (ABI)\<90). * Documented CVD: Ischemic stroke, previous carotid vascular interventions. * Signed informed consent. Exclusion Criteria: * Active neoplasia or very severe disease compromising short-medium term life expectancy. * Participation in interventional studies. * Patients already enrolled into the study from another participating center or in the previous enrolling phase.
Conditions4
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06275113